⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

BAYERCROP - Fundamental Analysis: Financial Health & Valuation

← Back to List

⭐ Rating: 3.2

Last Updated Time : 02 Aug 26, 04:58 pm

Key Parameters

⭐ Fundamental Rating: 3.2

Stock CodeBAYERCROP
Market Cap19,034 Cr.
Current Price4,230 ₹
High / Low6,540 ₹
Stock P/E27.6
Book Value660 ₹
Dividend Yield3.54 %
ROCE29.1 %
ROE23.7 %
Face Value10.0 ₹
DMA 504,277 ₹
DMA 2004,582 ₹
Chg in FII Hold0.08 %
Chg in DII Hold-0.25 %
PAT Qtr162 Cr.
PAT Prev Qtr95.7 Cr.
RSI50.7
MACD2.37
Volume29,017
Avg Vol 1Wk22,189
Low price4,030 ₹
High price6,540 ₹
PEG Ratio52.1
Debt to equity0.03
52w Index7.97 %
Qtr Profit Var13.1 %
EPS153 ₹
Industry PE21.8

✅ Positive

Bayer CropScience exhibits strong profitability driven by a high ROE and ROCE, coupled with a respectable dividend yield. Recent stake increase by Bayer AG indicates confidence in the company's long-term prospects. The company demonstrates robust revenue growth compared to the previous quarter.

⚠️ Limitation

The high P/E ratio reflects significant market expectations and valuation concerns, creating a substantial risk for investors. A downgrade to ‘Sell’ alongside technical weakness raises questions about short-term performance and potential headwinds.

📉 Company Negative News

Recent news indicates a downgrade to 'Sell' due to technical weakness and valuation concerns, suggesting negative sentiment among analysts. Technical momentum shifts towards bearish signals further exacerbate these concerns.

📈 Company Positive News

Bayer AG increasing its stake demonstrates confidence and potentially strengthens the company’s financial position. This move suggests potential strategic alignment between the parent company and CropScience division.

🏭 Industry

The agricultural sector is currently experiencing fluctuating demand due to global weather patterns, supply chain disruptions, and evolving crop protection regulations. Despite these challenges, the industry remains vital for food security, driving innovation in seeds, chemicals, and digital farming solutions. Competition is intense, with established players vying for market share alongside emerging biotech companies.

🧾 Conclusion

We recommend an entry zone between 4,030 ₹ and 4,230 ₹, representing a potential undervaluation based on the current P/E ratio relative to the industry average. Long-term holding guidance suggests focusing on Bayer CropScience’s leadership in key agricultural markets and its ongoing investments in research & development. The overall verdict is cautiously optimistic given the company's strong financials but necessitates careful monitoring of technical indicators and broader market sentiment.

Technical Analysis
Fundamental Analysis

NIFTY 50 · Fundamental

NEXT 50 · Fundamental

MIDCAP · Fundamental

SMALLCAP · Fundamental